Tolerability and outcomes of neuroendocrine tumors treated with PRRT and SBRT
{{output}}
There is interest in optimizing peptide receptor radionuclide therapy (PRRT) for the management of metastatic neuroendocrine neoplasms (NEN). The addition of stereotactic body radiation therapy (SBRT) may provide synergistic benefits by targeting specific site... ...
